Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07777211 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07777211 · ClinicalTrials.gov record · last posted 2026-08-20

A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer

StatusActive, Not Recruiting
PhasePhase 1/2
Started2025-08-14
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This is a Phase I/IIa, multicenter study designed to evaluate the safety, tolerability, and efficacy of GKL-006 injection in patients with ductal adenocarcinoma of pancreas.
Trial Details
NCT Number NCT07777211
Lead Sponsor Beijing Gene Key Life Technology Co., Ltd
Conditions Advanced Pancreatic Cancer, Ductal Adenocarcinoma of Pancreas
Enrollment 52 participants
Start Date 2025-08-14
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-20